The Defense Logistics Agency (DLA) awarded a $3,785.80 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. The contract has an ultimate completion date of December 12, 2024 and is not associated with any set-aside designation.
Generated 3/12/25, 10:07 AM